CVR Medical Corp. (CRRVF)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Jan 8, 2025
CVR Medical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | 2012 - 2016 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '22 Sep 30, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | 2012 - 2016 |
Cash & Equivalents | 0 | 0.09 | 0 | 0 | 0.07 | 0.46 | Upgrade
|
Cash & Short-Term Investments | 0 | 0.09 | 0 | 0 | 0.07 | 0.46 | Upgrade
|
Cash Growth | -6.94% | 2638.11% | 6.65% | -95.67% | -83.88% | 374.44% | Upgrade
|
Other Receivables | 0 | 0 | 0.01 | 0.01 | 0.03 | 0.03 | Upgrade
|
Receivables | 0 | 0 | 0.01 | 0.01 | 0.16 | 0.03 | Upgrade
|
Prepaid Expenses | - | - | 0.05 | 0.06 | 0.07 | 0.06 | Upgrade
|
Total Current Assets | 0.01 | 0.1 | 0.07 | 0.08 | 0.3 | 0.55 | Upgrade
|
Property, Plant & Equipment | - | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Other Intangible Assets | 0 | 0 | 1.15 | 1.13 | 1.08 | 1.17 | Upgrade
|
Total Assets | 0.01 | 0.1 | 1.22 | 1.21 | 1.38 | 1.72 | Upgrade
|
Accounts Payable | 1.2 | 1.26 | 1.18 | 0.63 | 0.37 | 0.01 | Upgrade
|
Accrued Expenses | 0.04 | 2.14 | 1.92 | 1.83 | 0.73 | 0.04 | Upgrade
|
Short-Term Debt | 0.6 | 0.5 | 0.28 | 0.04 | 0.03 | - | Upgrade
|
Other Current Liabilities | 2.7 | 0.37 | 0.19 | 0.83 | 0.05 | 0.06 | Upgrade
|
Total Current Liabilities | 4.55 | 4.28 | 3.56 | 3.32 | 1.17 | 0.11 | Upgrade
|
Long-Term Debt | - | 0.03 | 0.09 | 0.11 | - | - | Upgrade
|
Other Long-Term Liabilities | 0.27 | 0.25 | 0.25 | - | - | - | Upgrade
|
Total Liabilities | 4.82 | 4.55 | 3.91 | 3.43 | 1.17 | 0.11 | Upgrade
|
Common Stock | 25.49 | 25.44 | 25.35 | 25.35 | 22.91 | 17.4 | Upgrade
|
Retained Earnings | -33.15 | -32.57 | -30.75 | -30.58 | -25.44 | -18 | Upgrade
|
Comprehensive Income & Other | 2.85 | 2.67 | 2.71 | 3 | 2.74 | 2.21 | Upgrade
|
Shareholders' Equity | -4.81 | -4.46 | -2.69 | -2.22 | 0.21 | 1.61 | Upgrade
|
Total Liabilities & Equity | 0.01 | 0.1 | 1.22 | 1.21 | 1.38 | 1.72 | Upgrade
|
Total Debt | 0.6 | 0.53 | 0.36 | 0.15 | 0.03 | - | Upgrade
|
Net Cash (Debt) | -0.59 | -0.43 | -0.36 | -0.14 | 0.05 | 0.46 | Upgrade
|
Net Cash Growth | - | - | - | - | -90.08% | 374.44% | Upgrade
|
Net Cash Per Share | -0.01 | -0.00 | -0.00 | -0.00 | 0.00 | 0.01 | Upgrade
|
Filing Date Shares Outstanding | 132.23 | 132.23 | 126.38 | 126.38 | 126.38 | 64.94 | Upgrade
|
Total Common Shares Outstanding | 132.23 | 130.23 | 126.38 | 126.38 | 114.63 | 64.94 | Upgrade
|
Working Capital | -4.54 | -4.18 | -3.5 | -3.25 | -0.87 | 0.44 | Upgrade
|
Book Value Per Share | -0.04 | -0.03 | -0.02 | -0.02 | 0.00 | 0.02 | Upgrade
|
Tangible Book Value | -4.81 | -4.46 | -3.84 | -3.36 | -0.87 | 0.45 | Upgrade
|
Tangible Book Value Per Share | -0.04 | -0.03 | -0.03 | -0.03 | -0.01 | 0.01 | Upgrade
|
Updated Dec 1, 2022. Source: S&P Global Market Intelligence. Standard template. Financial Sources.